Koschut, D., Ray, D., Li, Z., Giarin, E., Groet, J., Alić, I., . . . Nižetić, D. (2020). RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia. Oncogene.
Stile di citazione ChicagoKoschut, David, et al. "RAS-protein Activation but Not Mutation Status Is an Outcome Predictor and Unifying Therapeutic Target for High-risk Acute Lymphoblastic Leukemia." Oncogene 2020.
Citazione MLAKoschut, David, et al. "RAS-protein Activation but Not Mutation Status Is an Outcome Predictor and Unifying Therapeutic Target for High-risk Acute Lymphoblastic Leukemia." Oncogene 2020.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.